Prescient Therapeutics Ltd

PTX

Company Profile

  • Business description

    Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.

  • Contact

    Level 4, 100 Albert Road
    South Melbourne
    MelbourneVIC3205
    AUS

    T: +61 396927222

    https://www.ptxtherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    12

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,741.9026.70-0.30%
CAC 407,779.1211.15-0.14%
DAX 4024,269.8353.75-0.22%
Dow JONES (US)42,319.74108.00-0.25%
FTSE 1008,814.953.910.04%
HKSE23,792.54114.43-0.48%
NASDAQ19,298.45162.04-0.83%
Nikkei 22537,741.61187.120.50%
NZX 50 Index12,563.4813.67-0.11%
S&P 5005,939.3031.51-0.53%
S&P/ASX 2008,515.7023.20-0.27%
SSE Composite Index3,385.361.260.04%

Market Movers